The global burn care market size was USD 2.9 Bn in 2022 and is likely to reach USD 5.1 Bn by 2031, expanding at a CAGR of 7.3% during 2023–2031. The growth of the market is attributed to the rising incidents of burn injuries.
Burn injuries may occur through fire accidents, electrical shocks, or chemical exposures. The degree of burn injuries may vary from minor scarring with excruciating pain and may be life-threatening as well. For treating such injuries through primary care burn ointments are the preferred treatments for burn care.
As per the World Health Organization reports (WHO) close to 1,80,000 fatalities are recorded annually due to fatal burn injuries. Awareness about burn care is on the rise among healthcare professionals and patients is a major factor that has boosted the burn care market globally.
Medications in the form of biologics that include skin grafts are used for treating burns. The growing use of antimicrobial burn wound dressings and bioactive dressings are widely used. These products are preferred for burn wound healing as they prevent infections and aid in the fast healing of injuries.
The COVID-19 pandemic affected the overall revenue of the global burn care market. The sudden disruption in the supply chain reduced admissions in hospitals thus, the experts postponed or rescheduled elective surgeries. This hampered the market to certain extent.
Burn Care Market Dynamics
Major Drivers
Increasing cases of burn injuries are major factors driving the market. Growing demand for skin grafts and their substitutes is expected to boost the market. Additionally, rising demand for minimally invasive surgery and government initiatives including biologics such as skin grafts and advanced dressings reimbursement policies is expected to fuel the market.
Existing Restraints
High cost of products & treatments associated with burn care and its surgery procedures is expected to restrain the market. Lack of skilled and trained experts is another factor restraining the market in the projection period.
Emerging Opportunities
Technological advancements in burn care surgeries and products including biologics and grafts are projected to create lucrative opportunities in the market. Biologics including advanced dressings and skin grafts are popular for treating partial burns. This is expected to create opportunities in the market in the coming years.
Scope of Burn Care Market Report
The report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Burn Care Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product (Biologics, Advanced Dressings, Traditional Dressings, and Others), Depth (Minor Thickness, Partial Thickness, and Full Thickness), Cause (Thermal Burn, Chemical Burn, Radiation Burn, Electrical Burn, and Others), and End-user (Hospitals, Clinics, Household, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
MediWound; Mölnlycke Health Care AB; Smith+Nephew; 3M; Cardinal Health; Medline Industries, Inc.; Convatec Inc.; Essity Aktiebolag (publ); PAUL HARTMANN AG; and DeRoyal Industries, Inc.
|
Market Segment Insights
Based on product, the burn care market is divided into biologics, advanced dressings, traditional dressings, and others. The advanced dressing segment is expected to expand at a significant pace during the forecast period attributed to the availability of a wide range of products and their application in wound operation. Advanced wound dressing products include collagen, hydrocolloid, alginate, hydrogel dressings, film dressings, and foam.
The biologics segment is projected to expand at a rapid pace during the projection period owing to the launch of novel products and extensive R&D investments. It involves the application of active biological agents & molecules including monoterpenes which are antimicrobials, antioxidants, and anti-inflammatories. Additionally, biologic dressings include skin grafts such as allografts, autografts, xenografts, or cadaveric human skin and tissue-engineered products designed for replacing the function and forming a skin. The key advantage of skin grafts or biologic skin dressings is that the skin is already available from the patients.
On the basis of depth, the global market is segregated into minor thickness, partial thickness, and full thickness. The minor thickness segment is projected to register a considerable CAGR during the projection period, as treating minor burns involves traditional products such as tapes, gauze, and bandages. Advanced dressings are usually used to treat minor burns.
The partial-thickness burn segment is expected to grow during the forecast period. According to the US Food and Drug Administration, around 40,000 people are hospitalized every year for the treatment of partial burns. Increasing demand and utilization of biologics for treating partial burns is fueling the segment.
On the basis of cause, the burn care market is segmented into thermal burn, chemical burn, radiation burn, electrical burn, and others. The thermal burn segment is expected to expand at a robust pace in the coming years due to a rising incidences of fire burn injuries. According to The American Burn Association, fire burn cause about 43% of the total burn admissions in burn centers. Children are particularly at risk of burn accidents such as hot drinks, hot showers, and steam.
The chemical burn segment is anticipated to hold a significant share of the market. It is caused when the skin and the fumes & corrosive products of chemicals come in contact with each other. Chemical fumes diffuse in the skin, which damages the tissue without causing any visible damage to the skin surface. Continuous exposure to chemicals damage the human tissues leading to scarring.
Based on end-user, the market is categorized into hospitals, clinics, household, and others. The hospital segment is anticipated to grow at a significant rate during the forecast period due to increased hospitalizations and admissions due to burn injuries. Hospitals have the provision for severe and advanced burn care products, which boosts the segment. They provide wide treatment options associated with burn care, which in turn, is responsible for the expansion of the segment.
In terms of region, the global burn care market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the projection period due to the rising incidence of burns in the region. According to a report by the American Burn Association, around 300 children are treated in emergency rooms in the US every day and about two children die from burn injuries. Children aged 16 and below account for around 26% of total burn care center admissions in the US. This results in the growth of the market in the region.
Segments
The burn care market has been segmented on the basis of
Product
- Biologics
- Advanced Dressings
- Traditional Dressings
- Others
Depth
- Minor Thickness
- Partial Thickness
- Full Thickness
Cause
- Thermal Burn
- Chemical Burn
- Radiation Burn
- Electrical Burn
- Others
End-user
- Hospitals
- Clinics
- Household
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- MediWound
- Mölnlycke Health Care AB
- Smith+Nephew
- 3M
- Cardinal Health
- Medline Industries, Inc.
- Convatec Inc.
- Essity Aktiebolag (publ)
- PAUL HARTMANN AG
- DeRoyal Industries, Inc.
Competitive Landscape
Key players operating in the global burn care market include MediWound; Mölnlycke Health Care AB; Smith+Nephew; 3M; Cardinal Health; Medline Industries, Inc.; Convatec Inc.; Essity Aktiebolag (publ); PAUL HARTMANN AG; and DeRoyal Industries, Inc.
These companies adopt strategies such as partnerships, acquisitions, promotions, collaboration, R&D investments, and product launches to boost their market share. For instance,
- On January 3 2023, MediWound received approval from US Food and Drug Administration (FDA) for NexoBird. It is an administered biological product that removes nonviable burn tissue by enzymatic action in patients with partial and full-thickness burns.
- In December 2022, MediWound announced approval for marketing NexoBird in India. NexoBird is an administered biological product that removes nonviable burn tissue by enzymatic action in patients with partial and full-thickness burns.
- In June 2022, Smith+Nephew launched an research & development and production center in the UK for advanced wound care business.
Request For Customization
Enquiry Before Buying
Speak With Analyst
